Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Open Forum
Funding new gen cancer drugs demands co-operation
Professor John Zalcberg says industry, government, clinicians and consumers must co-operate to ensure access to new generation of cancer medications.
Pipeline Monitor
AZ joins COPD rush, Novo wins in weight loss
AZ plans to join the COPD rush following encouraging phase III results for investigational drug PT003, while Novo wins EU approval for weight loss brand of Victoza.
Approvals Action
Important new approval for Roche
Roche has won Australian registration for Herceptin SC, the subcutaneous formulation of its breast and gastric cancer drug Herceptin while Celgene's Otezla is also new to the register.
Working Life
How to grab control of your pharma career
Lots of us start the year with career goals but staying on track day to day can be a challenge. Here are some tips for keeping your long term future in the frame.
Exclusive Interview
Appetite for Asian-based CTs still growing
There is no sign of dampening appetite for clinical trials in the Asia Pacific region, Novotech CEO Alek Safarian tells Pharma in Focus